QUOTED. March 7, 2018. Peter Ellingworth.
Check out what Association of British Healthcare Industries CEO Peter Ellingworth had to say about the risks of disrupting medtech supply chains with the UK’s pending exit from the EU.
"The nature of supply chains for health tech is such that even goods manufactured in the UK are often ultimately supplied to the [National Health Service] from distribution centers in the EU." –Peter Ellingworth, CEO, Association of British Healthcare Industries
Click here for a free trial of Medtech Insight